Research & Publications
Search result for "Solr search content"
Search Result for "*:*"
Research & Publications
Aphase1a/ 1bfirst-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors.
provider
Sahar Heydari, MPAS, PA-C Hematology-Oncology, Physician Assistant
Research & Publications
Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Research & Publications
The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration
Research & Publications